News
Lochmüller Lab Welcomes New Students
Our lab is growing! We are excited to introduce two new students who have joined the Lochmüller Lab this fall. Kelly Ho Kelly has joined as a Master’s student in Cellular and Molecular Medicine to study the effects of forskolin and salbutamol in a mouse model for congenital myasthenic...
Latest Issue of the Journal of Neuromuscular Diseases Now Available – July 2021
The Journal of Neuromuscular Diseases (JND) has announced the publication of a new issue of the journal! Volume 8, Issue 4 of the JND contains a record number 30 items comprised of research articles, meeting reports and reviews, many of them open access, and is now available online. The JND is dedicated to providing an...
Meet the Lochmüller Lab Clinical Team
Neuromuscular Clinic for adult patients at The Ottawa Hospital (TOH) Civic Campus As part of the team led by Dr. Jodi Warman Chardon, Hanns sees neuromuscular patients in clinic at the Ottawa Neuromuscular Centre, located at the Civic Campus of The Ottawa Hospital. This newly opened state-of-the-art centre is a...
Special issue of the Journal of Neuromuscular Diseases is devoted to the Treatabolome, designed to shorten diagnosis-to-treatment time for patients with rare diseases
In 2019, as part of the European Solve-RD project, Hanns Lochmüller, Gisèle Bonne and Rachel Thompson launched the Treatabolome, an initiative designed to extract details of effective treatments for rare diseases from the scientific literature and make them accessible through an online database that aims to allow patients to receive...
ProDGNE: Research Project to Develop an Innovative Therapeutic Compound to Treat GNE Myopathy
The Lochmüller Lab is proud to share its involvement in ProDGNE , a three-year transnational pre-clinical research project which aims to develop an innovative therapeutic compound to treat GNE Myopathy (GNEM), an ultra rare muscle disease affecting young adults. ProDGNE represents a unique collaboration among patients and European and Canadian...
Meet the lab’s two new members
Our lab is growing! We are excited to introduce two new members who have joined the Lochmüller lab this winter. Daniel O'Neil Daniel holds a BSc in Biochemistry from the University of Ottawa. During his undergraduate studies, he worked with Dr. Alexandre Blais’s laboratory where he studied the role of...
New publication: Modulation of the Acetylcholine Receptor Clustering Pathway Improves Neuromuscular Junction Structure and Muscle Strength in a Mouse Model of CMS
Our new paper, spearheaded by our lab manager Dr Spendiff, is now available online at Frontiers Molecular Neuroscience. This project is a product of an ongoing collaboration with the Zürich-based biotech company Neurotune AG. Neurotune AG’s drug NT1654 has shown efficacy in a number of animal models with muscle weakness,...
Invitation to submit to special issues of the Journal of Neuromuscular Diseases
The Journal of Neuromuscular Diseases has two exciting special issues that are open for submission of NMD research papers. One is a special issue dedicated to sharing unexpected or ‘negative’ data, and the other is a celebration of Prof. Terence Partridge’s career in the field of myogenesis and skeletal muscle...
Latest edition of the Journal of Neuromuscular Diseases now online – Sep 2020
A new issue of the Journal of Neuromuscular Diseases has recently been released. Read it below: Journal of Neuromuscular Diseases: Volume 7, issue 4 *Hanns is joint editor-in-chief of the Journal of Neuromuscular Diseases, together with Carsten Bönnemann of the NIH National Institute of Neurological Disorders and Stroke. Articles...
Meet the lab’s three new members
Our lab is growing! We are excited to introduce three new members who have joined the Lochmüller lab this summer. Kiran Polavarapu Dr Kiran Polavarapu completed his PhD in 2019 at the National Institute of Mental Health and Neurosciences (NIMHANS) in India. He is an M.B.B.S (Bachelor of Medicine and...
Treatabolome presentations now online
Within the European Solve-RD project, we participate in work to create a "treatabolome" - a database of evidence for treatments for rare disorders linked to the precise genetic defect. Many rare diseases do have treatments available, but frequently there is a substantial delay before patients affected by the disease receive...
New publications on neuromuscular transmission defects: international collaboration helps find answers
In rare diseases like the congenital myasthenic syndromes and other disorders of neuromuscular transmission, research results are frequently the result of international collaboration. Patients may be seen in clinic in one country, their DNA sequenced in another country, and the data analysed in a third, or researchers from multiple countries...
Latest edition of the Journal of Neuromuscular Diseases now online – Jun 2020
A new issue of the Journal of Neuromuscular Diseases has recently been released. Read it below: Journal of Neuromuscular Diseases: Volume 7, issue 3 (click to view it at the journal website) *Hanns is joint editor-in-chief of the Journal of Neuromuscular Diseases, together with Carsten Bönnemann of the NIH National...
The Lochmüller Lab on Lockdown
While the pandemic is still not over in Canada, and Ontario’s state of emergency will not be lifted before the end of June at the earliest, preparations are underway at the CHEO Research Institute to allow some research to restart in a carefully phased process over the coming weeks and...
Awards success for Lochmüller Lab researchers
We are very pleased to announce the success of several Lochmüller Lab team members in recent fellowship and scholarship competitions. Jarred Lau Master's student Jarred Lau received a Scholarship in Translational Research (STaR) award from the Éric Poulin Centre for Neuromuscular Disease. Jarred is investigating novel...
New publication: Advances in the diagnosis of inherited neuromuscular diseases and implications for therapy development
The neuromuscular field has seen rapid advances in recent years thanks to the increased use of next-generation sequencing and additional omics technologies like RNA sequencing and proteomics. Together with colleagues from Ottawa, Germany and the UK, we were delighted to write a new review for the Lancet Neurology in which...